Microwave ablation is an effective treatment modality for T1a and selected T1b renal cell carcinoma (RCC). Independent of the ...

Immunotherapy has transformed the treatment landscape for lung cancer, offering significant survival benefits for patients with advanced disease. Immune checkpoint inhibitors, such as PD-1 and PD-L1 ...

The FDA has extended its review of the ProSense cryoablation system for early-stage breast cancer, with a decision expected after the first quarter of 2025. The FDA has extended the review period for ...

Percutaneous ablation therapies currently play a major role in the management of T1a and T1b renal cell carcinoma (RCC). These therapies include thermal ablative technologies like radiofrequency (RFA) ...